Develops, manufactures and distributes vaccines and other pharmaceutical products
GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.
It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.
The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.
The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.
The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.
The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Vote Quantity Float Company-owned shares Total Float
Shareholders GlaxoSmithKline plc (GSK - London Stock Exchange) GlaxoSmithKline plc (GSK - Nyse)
Name Equities % BlackRock Investment Management (UK) Ltd. 207,257,650
4.22% Legal & General Investment Management Ltd. 147,931,457
3.01% The Vanguard Group, Inc. 118,400,253
2.41% Capital Research & Management Co. (Global Investors) 93,088,701
1.90% Norges Bank Investment Management 92,073,000
1.88% Woodford Investment Management LLP 66,402,112
1.35% State Street Global Advisors Ltd. 64,248,136
1.31% Schroder Investment Management Ltd. 57,188,782
1.16% Threadneedle Asset Management Ltd. 56,813,660
1.16% Capital Research & Management Co. (World Investors) 56,248,284
Name Equities % Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,379 6.19% 585,499,423 USD Innoviva Inc (INVA) 32,005,260 29.4% 342,456,282 USD Theravance Biopharma Inc (TBPH) 9,644,807 18.6% 307,476,447 USD JCR Pharmaceuticals Co Ltd (4552) 7,986,000 24.6% 195,208,027 USD Crispr Therapeutics AG (CRSP) 3,220,627 8.09% 65,249,903 USD Dong-A Socio Holdings Co Ltd (000640) 409,693 6.77% 53,085,737 USD GlaxoSmithKline S.A.E. 76,161,378 91.2% 38,686,934 USD GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 444,065,541 37.1% 22,203,277 USD Oncomed Pharmaceuticals Inc (OMED) 2,607,546 7.03% 20,104,180 USD Allergy Therapeutics plc (AGY) 10,118,000 1.70% 2,609,837 USD
GlaxoSmithKline plc : Connections
Business Council for Britain
Pharmaceutical Research & Manufacturers of America
American Academy of Arts & Sciences
The Council for Industry & Higher Education
European Federation of Pharmaceutical Industries & Assns
The University of Nottingham
National Theatre of Scotland
TFS Trial Form Support AB
United Way of Greater Philadelphia & Southern New Jersey
Office for Strategic Co-ordination of Health Research
French Academy of Sciences
Biotechnology Innovation Organization
Glaxosmithkline Australia Pty Ltd.
United Kingdom Department for Business, Innovation & Skills
Rockefeller Family Trust, Inc.
Massachusetts Institute of Technology
International AIDS Vaccine Initiative, Inc.
United Way of Greater Houston
Longwood Fund Management LLC
World Golf Foundation, Inc.
The Natural History Museum
The First Tee of Greater Houston
Company contact information 980 Great West road TW8 9GS Brentford, Greater London United Kingdom Phone : +44 (0)20 8047 5000 Fax : +44 (0)20 8047 7807 Internet : http://www.gsk.com
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
- ISIN Code :
- Bloomberg Code :
- Reuters Code :
- Datastream Code :
© 2017 People , Fundamentals and Ownership
© 2017 Cofisem